Testing positive plasma for SARS-CoV-2 to identify potential factors correlating with mild COVID-19 in Ghana, West Africa

  • WHO. WHO’s coronavirus (COVID-19) dashboard; 2021. p. 1–6. Accessed August 24, 2021.

    Google Scholar

  • Zeng H, Ma Y, Zhou Z, Liu W, Huang P, Jiang M, et al. Spectrum and clinical features of symptomatic and asymptomatic coronavirus disease 2019 (COVID-19) with and without pneumonia. Front Med. 2021;8:1–9.

    Article Google Scholar

  • Osei SA, Biney RP, Anning AS, Nortey LN, Ghartey-Kwansah G. Low incidence of severity and case fatality of COVID-19 in Africa; could malaria coinfection provide the missing link? BMC Infect Dis. 2022;22:1–11.

    Article Google Scholar

  • Monometers. Cases of coronavirus: Worldometers.info; 2022. p. 109–12. Accessed May 20, 2022.

    Google Scholar

  • Morang CM, Ngoi JM, Gyam J, Amuzu DSY, Nuertey BD, Soglo PM, et al. in Ghana from 2020-2 Nat Commun. 2022;13:1–11.

    Google Scholar

  • Wilkinson E, Giovanetti M, Tegally H, San JE, Lessells R, Cuadros D, et al. A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa. Science (80-). 2021;374:423–31.

    CAS Article Google Scholar

  • Forku R. WHO praises Africa’s response as virus cases decline: Health, Africa; 2021. p. 1–2. Accessed August 26, 2021.

    Google Scholar

  • Quashie PK, Mutungi JK, Dzabeng F, Oduro-Mensah D, Opurum PC, Tapela K, et al. Trends in the prevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in selected regions of Ghana. Welcome Open Nothing. 2021;6:173.

    Article Google Scholar

  • Uyoga S, Adetifa IMO, Karanja HK, Nyagwange J, Tuju J, Wanjiku P, et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Kenyan blood donors. Science (80-). rev. 2021;371:79–8

    CAS Article Google Scholar

  • Lawal Y. Africa’s low COVID-19 death rate: a paradox? Int J Infect Dis. 2021;102:118–22.

    CAS Article PubMed Google Scholar

  • [ PubMed ][ Cross Ref ]Kalungi A, Kinyanda E, Akena DH, Caleb P, Bisangwa IM. Less severe cases of COVID-19 in sub-Saharan Africa: could co-infection or a recent history of Plasmodium falciparum infection be protective? Front Immunol. 2021;12:1–5

    Article Google Scholar

  • Oleribe OO, Suliman AAA, Taylor-Robinson SD, Corrah T. Possible reasons why sub-Saharan Africa experienced a less severe COVID-19 pandemic in 2020. J Multidiscip Healthc. 2021;14:3267–71.

    PubMed PubMed Central Article Google Scholar

  • Mulenga LB, Hines JZ, Fwoloshi S, Chirwa L, Siwingwa M, Yingst S, et al. Prevalence of SARS-CoV-2 in six districts of Zambia in July 2020: a cross-sectional cluster sample survey. Lancet Globe Health. 2021;9:e773–81.

    PubMed PubMed Central Article Google Scholar

  • Chibwana MG, Jere KC, Kamn’gona R, Mandolo J, Katunga-Phiri V, Tembo D, et al. High seroprevalence of SARS-CoV-2 in healthcare workers, but relatively low number of deaths in urban Malawi. with Rxiv. 2020

  • Olayanju O, Bamidele O, Edem F, Eseile B, Amoo A, Nwaokenye J, et al. SARS-CoV-2 seropositivity in asymptomatic frontline healthcare workers in Ibadan, Nigeria. Am J Trop Med Hyg. 2021;104:91–4.

    CAS Article PubMed Google Scholar

  • Tang Y, Liu J, Zhang D, Xu Z, Ji J, Wen C. Cytokine storm in COVID-19: current evidence and treatment strategies. Front Immunol. 2020;11:1708.

  • Riou C, du Bruyn E, Stek C, Daroowala R, Goliath RT, Abrahams F, et al. Relationship of the SARS-CoV-2-specific CD4 response to the severity of COVID-19 and the impact of coinfection with HIV-1 and tuberculosis. J Clin Invest. 2021;131:1–15.

    Article Google Scholar

  • Zhao J, Yang Y, Huang H, Li D, Gu D, Lu X, et al. Relationship between ABO blood group and susceptibility to coronavirus disease 2019 (COVID-19). Clin Infect Dis. 2020. https://doi.org/10.1093/cid/ciaa1150.

  • Giamarellos-Bourboulis EJ, Netea MG, Rovina N, Akinosoglou K, Antoniadou A, Antonakos N, et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Host cell microbe. 2020;27:992–1000.e3.

    CAS PubMed PubMed Central Article Google Scholar

  • Lucas C, Wong P, Klein J, Castro TBR, Silva J, Sundaram M, et al. Longitudinal analyzes reveal immunological errors in severe COVID-19. Nature. 2020;584:463–9.

    CAS PubMed PubMed Central Article Google Scholar

  • Moderbacher CR, Ramírez SI, Dan JM, Smith DM, Sette A, Moderbacher CR, et al. Article Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity ll Antigen-specific adaptive immunity to SARS-CoV-2 in COVID-19 acute and associations with age and severity of illness. cell 2020;183:996–1012.e19.

    Article Google Scholar

  • Rowaiye AB, Okpalefe OA, Adejoke OO, Ogidigo JO, Oladipo OH, Ogu AC, et al. Attenuation of the effects of the novel cytokine storm induced by COVID-19 (SARS-CoV-2) infection and its implications. J Inflammation Res. 2021;14:1487–510.

    PubMed PubMed Central Article Google Scholar

  • Chi Y, Ge Y, Wu B, Zhang W, Wu T, Wen T, et al. Serum profile of cytokines and chemokines in relation to 2019 coronavirus disease severity in China. J Infect Dis. 2020;222:746–54.

    CAS Article PubMed Google Scholar

  • Long QX, Tang XJ, Shi QL, Li Q, Deng HJ, Yuan J, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. 2020;26:1200–4.

    CAS Article PubMed Google Scholar

  • Liu Y, Yang Y, Zhang C, Huang F, Wang F, Yuan J, et al. Clinical and biochemical indices of linked 2019-nCoV-infected patients. Science Life China Science. 2020;63:364–74.

    CAS PubMed PubMed Central Article Google Scholar

  • Yang P, Wang X. COVID-19: a new challenge for humans. Cell Mol Immunol. 2020;17:555–7.

    CAS PubMed PubMed Central Article Google Scholar

  • Chen Y, Wang J, Liu C, Su L, Zhang D, Fan J, et al. IP-10 and MCP-1 as biomarkers associated with disease severity of COVID-19. Mol Med. 2020;26(1):1–2.

    Article Google Scholar

  • Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts severity and survival in COVID-19. Nat Med. 2020;26:1636–43.

    PubMed PubMed Central Article Google Scholar

  • Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507–13.

    CAS PubMed PubMed Central Article Google Scholar

  • Pan Y, Zhang D, Yang P, Poon LLM, Wang Q. Viral load of SARS-CoV-2. Lancet Infect Dis. 2020;20:411–2.

    CAS PubMed PubMed Central Article Google Scholar

  • Liu Y, Tan W, Chen H, Zhu Y, Wan L, Jiang K, et al. Dynamic changes in lymphocyte subsets and parallel cytokine levels in severe and critical COVID-19 patients. BMC Infect Dis. 2021;21:1–10.

    CAS Article Google Scholar

  • Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8.

    CAS Article PubMed Google Scholar

  • Wang X, Guo X, Xin Q, Pan Y, Hu Y, Li J, et al. Neutralizing antibody responses to severe acute respiratory syndrome coronavirus 2 in hospitalized and convalescent patients with coronavirus disease 2019. Clin Infect Dis Infect Dis. 2020;10:2688–94.

    Article Google Scholar

  • Efrati S, Catalonia M, Abu Hamed R, Hadanny A, Bar-Chaim A, Benveniste-Levkovitz P, et al. Early and long-term antibody kinetics of asymptomatic and mild patients with COVID-19 disease. Rep. Science 2021;11:13780.

    CAS PubMed PubMed Central Article Google Scholar

  • Marchi S, Viviani S, Remarque EJ, Ruello A, Bombardieri E, Bollati V, et al. Characterization of the antibody response in asymptomatic and symptomatic SARS-CoV-2 infection. PLoS One. 2021;16:e2539977.

  • Mudd JL. A microplate method for reverse ABO typing of blood spots. J Forensic Science. 1986;31:418–25.

    CAS Article PubMed Google Scholar

  • Muñoz-Carrillo JL, Contreras-Cordero JF, Gutiérrez-Coronado O, Villalobos-Gutiérrez PT, Ramos-Gracia LG, Hernández-Reyes VE. The cytokine profile plays a crucial role in activating the immune system to eliminate infectious pathogens. In: Rajeev Tyagi P, Bisen Rakash S, editors. Activation and immunomodulation of the immune response. London: Intechopen; 2018. p. 9–12.

    Google Scholar

  • Ayouba A, Thaurignac G, Morquin D, Tuaillon E, Raulino R, Reynes J, et al. Multiplex and dynamic detection of IgG antibodies against SARS-CoV2 and the highly pathogenic human coronaviruses SARS-CoV and MERS-CoV Ahidjo. J Clin Virol. 2020;129:104521.

    CAS PubMed PubMed Central Article Google Scholar

  • Perraut R, Varela M, Mbengue.

  • Leave a Comment

    Your email address will not be published. Required fields are marked *